The relationship between FGL1 and liver steatosis in diabetic patients with or without NAFLD was investigated and a significant increase of serum FGL1 in type 2 diabetics and NAFLD patients, providing evidence that FGL1 elevation in both diseased conditions may facilitate hepatic lipid accumulation 28. The gene discussed is FGL1; the disease is metabolic dysfunction-associated steatotic liver disease.